Towards mapping neuro-behavioral heterogeneity of psychedelic neurobiology in humans
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Towards mapping neuro-behavioral heterogeneity of psychedelic neurobiology in humans
Authors
Keywords
-
Journal
BIOLOGICAL PSYCHIATRY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-12-07
DOI
10.1016/j.biopsych.2022.10.021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Repeated low doses of LSD in healthy adults: A placebo‐controlled, dose–response study
- (2022) Harriet Wit et al. ADDICTION BIOLOGY
- Reproducible brain-wide association studies require thousands of individuals
- (2022) Scott Marek et al. NATURE
- Increased global integration in the brain after psilocybin therapy for depression
- (2022) Richard E. Daws et al. NATURE MEDICINE
- The promises and perils of psychedelic pharmacology for psychiatry
- (2022) Tristan D. McClure-Begley et al. NATURE REVIEWS DRUG DISCOVERY
- Differential contributions of serotonergic and dopaminergic functional connectivity to the phenomenology of LSD
- (2022) Timothy Lawn et al. PSYCHOPHARMACOLOGY
- Correction: Mapping brain-behavior space relationships along the psychosis spectrum
- (2022) Jie Lisa Ji et al. eLife
- Functional neuroimaging in psychiatry and the case for failing better
- (2022) Matthew M. Nour et al. NEURON
- Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
- (2022) Federico Cavanna et al. Translational Psychiatry
- Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder
- (2022) Michael P. Bogenschutz et al. JAMA Psychiatry
- Self-blinding citizen science to explore psychedelic microdosing
- (2021) Balázs Szigeti et al. eLife
- Trial of Psilocybin versus Escitalopram for Depression
- (2021) Robin Carhart-Harris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study
- (2021) Michiel van Elk et al. PSYCHOPHARMACOLOGY
- Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses—A Simultaneous EEG–FMRI Study
- (2021) Patricia Duerler et al. CEREBRAL CORTEX
- Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals
- (2021) Drummond E-Wen McCulloch et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis
- (2021) Patrick Vizeli et al. Scientific Reports
- Mapping brain-behavior space relationships along the psychosis spectrum
- (2021) Jie Lisa Ji et al. eLife
- Transcriptomics-informed large-scale cortical model captures topography of pharmacological neuroimaging effects of LSD
- (2021) Joshua B Burt et al. eLife
- Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study
- (2021) Josephine Marschall et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults
- (2021) Conor H. Murray et al. PSYCHOPHARMACOLOGY
- Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
- (2021) Manoj K. Doss et al. Translational Psychiatry
- Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity
- (2020) Katrin H. Preller et al. BIOLOGICAL PSYCHIATRY
- Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression
- (2020) Lea J Mertens et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Tripping on nothing: placebo psychedelics and contextual factors
- (2020) Jay A. Olson et al. PSYCHOPHARMACOLOGY
- Emotions and brain function are altered up to one month after a single high dose of psilocybin
- (2020) Frederick S. Barrett et al. Scientific Reports
- Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials
- (2020) Juan José Fuentes et al. Frontiers in Psychiatry
- Subacute effects of the psychedelic ayahuasca on the salience and default mode networks
- (2020) Lorenzo Pasquini et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention
- (2020) Frederick S. Barrett et al. NEUROIMAGE
- Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
- (2020) N. L. Mason et al. NEUROPSYCHOPHARMACOLOGY
- Canonical Correlation Analysis for Identifying Biotypes of Depression
- (2020) Agoston Mihalik et al. Biological Psychiatry-Cognitive Neuroscience and Neuroimaging
- Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study
- (2020) Nadia R.P.W. Hutten et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers
- (2020) Johannes G Ramaekers et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans
- (2020) Dea Siggaard Stenbæk et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
- (2020) Franz X. Vollenweider et al. NATURE REVIEWS NEUROSCIENCE
- Plasma psilocin critically determines behavioral and neurobiological effects of psilocybin
- (2020) Martin K. Madsen et al. NEUROPSYCHOPHARMACOLOGY
- Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review
- (2020) Genís Ona et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- The History of Psychedelics in Psychiatry
- (2020) David E. Nichols et al. PHARMACOPSYCHIATRY
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- (2020) Alan K. Davis et al. JAMA Psychiatry
- Evaluating the evidence for biotypes of depression: Methodological replication and extension of
- (2019) Richard Dinga et al. NeuroImage-Clinical
- Effective connectivity changes in LSD-induced altered states of consciousness in humans
- (2019) Katrin H. Preller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
- (2019) Martin K. Madsen et al. NEUROPSYCHOPHARMACOLOGY
- Childhood trauma history is linked to abnormal brain connectivity in major depression
- (2019) Meichen Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Receptor-Enriched Analysis of functional connectivity by targets (REACT): A novel, multimodal analytical approach informed by PET to study the pharmacodynamic response of the brain under MDMA
- (2019) Ottavia Dipasquale et al. NEUROIMAGE
- REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
- (2019) R. L. Carhart-Harris et al. PHARMACOLOGICAL REVIEWS
- Neurobiological divergence of the positive and negative schizophrenia subtypes identified upon a new factor-structure of psychopathology using non-negative factorization: An international machine-learning study
- (2019) Ji Chen et al. BIOLOGICAL PSYCHIATRY
- Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects
- (2019) Lukasz Smigielski et al. NEUROIMAGE
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers
- (2019) Neiloufar Family et al. PSYCHOPHARMACOLOGY
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
- (2018) Fernanda Palhano-Fontes et al. PSYCHOLOGICAL MEDICINE
- The Adolescent Brain Cognitive Development (ABCD) study: Imaging acquisition across 21 sites
- (2018) B.J. Casey et al. Developmental Cognitive Neuroscience
- Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD
- (2018) Gustavo Deco et al. CURRENT BIOLOGY
- Hierarchy of transcriptomic specialization across human cortex captured by structural neuroimaging topography
- (2018) Joshua B. Burt et al. NATURE NEUROSCIENCE
- Linked dimensions of psychopathology and connectivity in functional brain networks
- (2018) Cedric Huchuan Xia et al. Nature Communications
- Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression
- (2018) Nikolaos Koutsouleris et al. JAMA Psychiatry
- Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor
- (2018) Katrin H Preller et al. eLife
- Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities
- (2017) Frederic Sampedro et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A multiregional proteomic survey of the postnatal human brain
- (2017) Becky C. Carlyle et al. NATURE NEUROSCIENCE
- Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression
- (2017) Leor Roseman et al. NEUROPHARMACOLOGY
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
- (2017) R. L. Carhart-Harris et al. PSYCHOPHARMACOLOGY
- Psychedelic Drugs in Biomedicine
- (2017) Evan J. Kyzar et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
- (2017) Robin L Carhart-Harris et al. Scientific Reports
- Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience
- (2016) Thomas Pokorny et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System
- (2016) Vincent Beliveau et al. JOURNAL OF NEUROSCIENCE
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Resting-state connectivity biomarkers define neurophysiological subtypes of depression
- (2016) Andrew T Drysdale et al. NATURE MEDICINE
- The Philadelphia Neurodevelopmental Cohort: A publicly available resource for the study of normal and abnormal brain development in youth
- (2016) Theodore D. Satterthwaite et al. NEUROIMAGE
- Effects of serotonin 2A/1A receptor stimulation on social exclusion processing
- (2016) Katrin H. Preller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The paradoxical psychological effects of lysergic acid diethylamide (LSD)
- (2016) R. L. Carhart-Harris et al. PSYCHOLOGICAL MEDICINE
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
- (2015) Michael P Bogenschutz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A positive-negative mode of population covariation links brain connectivity, demographics and behavior
- (2015) Stephen M Smith et al. NATURE NEUROSCIENCE
- PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
- (2015) Wesley K Kroeze et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
- (2015) Wesley K Kroeze et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
- (2015) Cathie Sudlow et al. PLOS MEDICINE
- The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network
- (2015) Fernanda Palhano-Fontes et al. PLoS One
- Neuromodulation by acetylcholine: examples from schizophrenia and depression
- (2014) Michael J Higley et al. CURRENT OPINION IN NEUROBIOLOGY
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
- (2014) Peter Gasser et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
- (2014) Matthew W Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Bipolar and Schizophrenia Network for Intermediate Phenotypes: Outcomes Across the Psychosis Continuum
- (2014) C. A. Tamminga et al. SCHIZOPHRENIA BULLETIN
- Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations
- (2013) M. Kometer et al. JOURNAL OF NEUROSCIENCE
- The WU-Minn Human Connectome Project: An overview
- (2013) David C. Van Essen et al. NEUROIMAGE
- Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: Relevance to DSM-5
- (2013) Deanna M. Barch et al. SCHIZOPHRENIA RESEARCH
- Beyond the connectome: How neuromodulators shape neural circuits
- (2012) Cornelia I. Bargmann BIOESSAYS
- Neuromodulation of Brain States
- (2012) Seung-Hee Lee et al. NEURON
- Neuromodulation of Neuronal Circuits: Back to the Future
- (2012) Eve Marder NEURON
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
- (2012) R. L. Carhart-Harris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Should We Expect “Neural Signatures” forDSMDiagnoses?
- (2011) Seth J. Gillihan et al. JOURNAL OF CLINICAL PSYCHIATRY
- Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers
- (2011) Boris B Quednow et al. NEUROPSYCHOPHARMACOLOGY
- Cognition in schizophrenia: core psychological and neural mechanisms
- (2011) Deanna M. Barch et al. TRENDS IN COGNITIVE SCIENCES
- Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies
- (2010) Erich Studerus et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
- (2010) Franz X. Vollenweider et al. NATURE REVIEWS NEUROSCIENCE
- Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)
- (2010) Erich Studerus et al. PLoS One
- Human hallucinogen research: guidelines for safety
- (2008) MW Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Serotonin research: contributions to understanding psychoses
- (2008) M GEYER et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started